These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22416)

  • 41. Beta-adrenoreceptor blockers and CaCl2-induced arrhythmias in the rat: discrepancies between antiarrhythmic properties and survival rate.
    Evangelista S; Grimaldi G; Maggi CA; Manzini S; Meli A
    Pharmacology; 1983; 27(2):103-9. PubMed ID: 6136995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD; Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 44. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.
    Wascher TC; Dittrich P; Kukovetz WR
    Arzneimittelforschung; 1991 Feb; 41(2):119-24. PubMed ID: 2043172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study of the effects of OPC-1085 and propranolol on isolated guinea pig atrium.
    Imanaga I; Sakamoto Y; Tomita T
    Jpn J Pharmacol; 1977 Apr; 27(2):227-32. PubMed ID: 18629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antiarrhythmic action of penbutolol].
    Boissier JR; Coutte R; Bertin MC; Giudicelli JF
    Therapie; 1974; 29(2):261-9. PubMed ID: 4152641
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
    Cambridge D; Whiting MV; Allan G
    Br J Pharmacol; 1988 Jan; 93(1):165-75. PubMed ID: 2894874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of newly synthesized beta-adrenergic blockers, OPC 1085 and SQ 11725, with pindolol and propranolol in the blood-perfused canine SA node and papillary muscle preparations.
    Hashimoto K; Kimura T; Yabuuchi Y
    Jpn J Pharmacol; 1976 Aug; 26(4):504-6. PubMed ID: 12390
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist.
    Fekete MI; Elekes I; Kürti M; Borvendég J
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):190-202. PubMed ID: 6111982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].
    Masumoto S; Inoue H; Maruyama Y
    Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):517-25. PubMed ID: 44259
    [No Abstract]   [Full Text] [Related]  

  • 52. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K; Takami N; Ozaki M
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD; Ekue JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 4398093
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models.
    Xue Y; Tanabe S; Nabuchi Y; Hashimoto K
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):239-47. PubMed ID: 9700986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiarrhythmic effects of selective beta 1- and beta 2- and nonselective beta-adrenoceptor blockade in normokalaemic and dietary-induced hypokalaemic rats.
    Winslow E; Walker G; Mason R
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):673-80. PubMed ID: 2481179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs.
    Himori N; Honma S; Izumi A; Ishimori T
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Feb; 316(1):19-23. PubMed ID: 6116195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of beta-adrenoceptor antagonism upon delayed reperfusion arrhythmias in conscious dogs.
    Todt H; Krumpl G; Krejcy K; Raberger G
    Eur J Pharmacol; 1991 Apr; 196(2):109-15. PubMed ID: 1678714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride].
    Femmer K; Poppe H; Heer S; Bartsch R
    Pharmazie; 1985 Dec; 40(12):836-40. PubMed ID: 3841597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs.
    Shibuya T; Hashimoto K; Imai S
    J Cardiovasc Pharmacol; 1983; 5(4):538-45. PubMed ID: 6193348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.